Purinergic Signaling
| Category | Mechanisms |
|---|---|
| Also known as | ATP Signaling, P1/P2 Receptor Signaling, Adenosine Signaling |
| Last updated | 2026-04-14 |
| Reading time | 4 min read |
| Tags | extracellular-atpadenosineion-channelsgpcrinflammation |
Overview
Nucleotides are best known as the energy currency of the cell, but they also serve as rapid extracellular messengers. Purinergic signaling — first proposed by Geoffrey Burnstock in the early 1970s against initial skepticism — is now recognized as one of the most evolutionarily ancient cell-communication systems, present in plants, animals, and single-celled eukaryotes. ATP and related nucleotides are released from cells by regulated vesicular exocytosis, membrane channels (pannexins, connexins), or cell lysis, and act on a diverse receptor superfamily before being rapidly degraded by ectoenzymes.
For peptide researchers, purinergic signaling matters because it intersects with nearly every peptide-responsive tissue: inflammation, platelet aggregation, neurotransmission, and vascular tone all involve ATP, ADP, or adenosine as co-messengers.
How It Works
Receptor Families
Two broad families detect purines and pyrimidines:
- P1 receptors (adenosine receptors) — A1, A2A, A2B, A3 — all class A GPCRs. A1 and A3 typically couple to Gi (inhibiting adenylyl cyclase); A2A and A2B couple to Gs (raising cAMP).
- P2 receptors — divided into P2X (ion channels, subunits P2X1-7) activated by ATP, and P2Y (GPCRs, P2Y1, 2, 4, 6, 11, 12, 13, 14) activated by various nucleotides including ATP, ADP, UTP, UDP, and UDP-glucose.
P2X receptors form trimeric ligand-gated cation channels permeable to Na+, K+, and importantly Ca2+, connecting purinergic input to calcium-calmodulin signaling. P2X7 is notable for its ability to form a large membrane pore during prolonged activation, permitting large molecule passage — a central event in inflammasome biology and pyroptosis.
Release and Degradation
ATP is released by:
- Exocytosis from synaptic vesicles (co-released with classical neurotransmitters).
- Pannexin-1 channels opened during apoptotic "find-me" signaling, inflammasome activation, or mechanical stress.
- Connexin hemichannels.
- Passive leak from damaged or dying cells.
A cascade of ectoenzymes shapes the signal:
- CD39 (NTPDase1) converts ATP → ADP → AMP.
- CD73 converts AMP → adenosine.
- Adenosine deaminase (ADA) converts adenosine → inosine.
The CD39/CD73 axis thus switches pro-inflammatory ATP into immunosuppressive adenosine — a critical checkpoint in cancer and infection.
Biological Roles
Inflammation and Immunity
Extracellular ATP is a prototypical damage-associated molecular pattern (DAMP). P2X7 activation on macrophages triggers NLRP3 inflammasome assembly, caspase-1 activation, IL-1β and IL-18 maturation, and often pyroptosis. It acts in concert with Toll-like receptor priming signals. Adenosine, by contrast, dampens inflammation through A2A receptors on T cells, macrophages, and neutrophils, and is a major tumor immunosuppressive signal.
Neurotransmission
ATP is a co-transmitter at many synapses and functions as a fast excitatory transmitter through P2X receptors. Adenosine at A1 receptors is the molecular target of caffeine (an antagonist), explaining caffeine's alerting effects.
Platelets and Hemostasis
ADP acting on P2Y12 is a central amplifier of platelet aggregation — the target of clopidogrel and similar antiplatelet drugs.
Vascular Tone, Smooth Muscle, Pain
Purinergic signaling regulates vasodilation (A2A, A2B), smooth muscle contraction (P2Y in bladder, gut), and nociception (P2X3 on sensory neurons is a key pain receptor).
Cell Death and Regeneration
Dying cells release ATP as a "find-me" signal that recruits phagocytes. Sustained P2X7 activation can drive cell death, connecting purinergic input to apoptosis and pyroptosis.
Relevance to Peptides
- Neuropeptide co-release with ATP: purinergic co-transmission occurs with substance P, CGRP, and other neuropeptides in sensory and autonomic nerves.
- Peptide-derived P2X antagonists: toxins from spiders and other venoms include peptide antagonists of P2X receptors, inspiring peptide drug leads for chronic pain (see venom-derived peptides in the research section).
- CD73/CD39 peptide inhibitors: blocking adenosine production in the tumor microenvironment is a hot oncology target, with peptide and antibody approaches in development.
- Bradykinin overlap: the kinin-kallikrein system and purinergic signaling converge on inflammation and vascular pain.
Therapeutic Implications
Established purinergic drugs include adenosine itself (supraventricular tachycardia), dipyridamole, clopidogrel/ticagrelor (P2Y12), theophylline and caffeine (adenosine receptor antagonists), and regadenoson (A2A agonist for cardiac stress testing). Emerging targets include P2X7 antagonists for chronic pain and inflammatory disease, P2X3 antagonists for refractory cough (gefapixant), and A2A antagonists for Parkinson's disease and cancer immunotherapy.
Current Questions
How to harness P2X7 modulation without immune compromise, how the CD39/CD73 axis coordinates with the complement system and TLRs in sterile inflammation, and how peptide-based purinergic modulators can exploit allosteric and tissue-specific sites remain open. Purinergic signaling also plays underappreciated roles in metabolism, cardiac ischemia, and fibrosis that continue to be explored.
Related entries
- Calcium-Calmodulin Pathway— The calcium-calmodulin pathway converts transient cytosolic calcium spikes into a wide array of downstream enzymatic responses, governing processes from muscle contraction to gene transcription.
- GPCR Signaling— G-protein coupled receptors constitute the largest family of membrane receptors in the human genome, transducing extracellular signals from peptide hormones, neurotransmitters, and sensory stimuli into intracellular responses through heterotrimeric G proteins and beta-arrestin pathways.
- NF-kB Pathway— The NF-kB pathway is the master transcriptional regulator of the inflammatory and innate immune response, controlling the expression of cytokines, chemokines, adhesion molecules, and survival genes in response to infection, injury, and stress.
- Pyroptosis— Pyroptosis is a highly inflammatory form of programmed cell death executed by gasdermin family pore-forming proteins, central to innate immunity and many inflammatory diseases.
- Toll-Like Receptors— Toll-like receptors are a family of pattern recognition receptors that detect conserved microbial structures and endogenous danger signals, activating innate immune responses through NF-kB, MAPK, and interferon regulatory factor signaling cascades.